Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Inc. (AUPH) is a healthcare company (biotechnology) based in Canada. The share price is $15.35, down 0.84% on the day, which values the company at $2.06B. Price as of 17 Nov 2026, 18:25 UTC, from Yahoo Finance.

Key facts

Share price
$15.35−0.84% today
Market value
$2.06B
P/E ratio
6.7×last 12 months
Forward P/E
13.2×
Funk Score
86/100
Against its own history
About its usual priceusual price $15.36
200-week average
$10.3748% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Aurinia Pharmaceuticals Inc. in more detail

AUPH trades at 6.7× its last twelve months' earnings, 13.2× next year's expected earnings, 6.4× sales. Measured against its own history, the price is 0% below what its usual multiples would imply ($15.36) — about its usual price. It sits 48% above its 200-week average of $10.37.

Over the last five fiscal years Aurinia Pharmaceuticals Inc. has compounded revenue 41.4% a year. Its Funk Score is 86 out of 100 (financial strength 9.5, profitability 8.5, growth 9.3, value 6.9, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score. Worth checking: Beneish M-score flags the accounts; Profit is not turning into cash.

Aurinia Pharmaceuticals Inc. (AUPH): questions and answers

What is AUPH's P/E ratio?

Aurinia Pharmaceuticals Inc. trades at 6.7× its last twelve months' earnings and 13.2× next year's expected earnings.

What is Aurinia Pharmaceuticals Inc.'s market cap?

Aurinia Pharmaceuticals Inc. is valued at $2.06B at a share price of $15.35.

Is AUPH overvalued or undervalued?

Against its own history, AUPH is about its usual price: the price is 0% below the $15.36 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is AUPH above its 200-week moving average?

Yes. AUPH is 48.1% above its 200-week average of $10.37. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Aurinia Pharmaceuticals Inc. growing?

Over the last five fiscal years Aurinia Pharmaceuticals Inc.'s revenue grew 41.4% a year.

Does AUPH pay a dividend?

Aurinia Pharmaceuticals Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Aurinia Pharmaceuticals Inc. (AUPH) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/AUPH

Underlying data: Yahoo Finance; company filings with the SEC.